oncology
Ipsen appoints two leading R&D experts in bid to strengthen oncology arm
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research
French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
NICE decision could limit future development of CAR T therapies; Evelyn Warner comments on NICE’s decision making process
September 25, 2018Research and Development CAR T, CAR-T, Cancer, Duff and Phelps, Kymriah, access, oncology, pricing
Lack of access to CAR T therapies in the United Kingdom could hinder the development of effective personalised cancer treatments, …
Widening the focus on innovations in cancer treatment
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma
Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
Shire hands over its oncology franchise to Servier for $2.4bn
August 31, 2018Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
“Radical radiotherapy” cuts required treatments from 37 to 5
August 14, 2018Manufacturing and Production Cancer, oncology, pharma, radiotherapy
Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …
Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna
August 2, 2018Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma
Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …
BMS’ Opdivo becomes first immuno-oncology agent available in China
June 18, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma
Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
Eli Lilly’s President of Oncology to retire
June 5, 2018Research and Development Cancer, Eli Lilly, appointment, oncology, pharma
Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of …
Lilly chalks up another acquisition with AurKa for $575m
May 14, 2018Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma
Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …
The new and improved Spring 2018 edition of Pharmafile is available to read online now!
May 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile
The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Looking to the future of oncology
April 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma
The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen
April 3, 2018Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma
AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
The April 2018 issue of Pharmafocus is now live!
March 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma
As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …
Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory
March 5, 2018Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma
Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …
Latest content
FibroFind appoints Lee Borthwick as CEO
